Eisai
4523.T
#2079
Rank
โ‚น890.54 B
Marketcap
โ‚น3,155
Share price
6.09%
Change (1 day)
20.95%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Revenue for Eisai (4523.T)

Revenue in 2026 (TTM): โ‚น486.59 Billion

According to Eisai's latest financial reports the company's current revenue (TTM ) is โ‚น514.30 Billion. In 2025 the company made a revenue of โ‚น485.16 Billion an increase over the revenue in the year 2024 that were of โ‚น443.82 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eisai from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น486.59 B0.29%
2025 โ‚น485.16 B9.32%
2024 โ‚น443.82 B0.74%
2023 โ‚น440.55 B-4.29%
2022 โ‚น460.29 B-2.66%
2021 โ‚น472.87 B-3.16%
2020 โ‚น488.30 B12.95%
2019 โ‚น432.33 B8.61%
2018 โ‚น398.07 B22.8%
2017 โ‚น324.16 B-2.86%
2016 โ‚น333.69 B6.97%
2015 โ‚น311.94 B-5.29%
2014 โ‚น329.36 B-10.05%
2013 โ‚น366.15 B-5.13%
2012 โ‚น385.93 B-12.23%
2011 โ‚น439.71 B4.26%
2010 โ‚น421.74 B8.7%
2009 โ‚น387.97 B